title: Medicare's Part D Drug Benefit At 10 Years: Firmly Established But Still Evolving.
authors.affiliation: John F. Hoadley (jfh7@georgetown.edu) is a research professor in the Health Policy Institute at Georgetown University, in Washington, D.C.
authors.forename: John F
authors.initials: JF
authors.lastname: Hoadley
authors.affiliation: Juliette Cubanski is associate director of the Program on Medicare Policy at the Henry J. Kaiser Family Foundation in Menlo Park, California.
authors.forename: Juliette
authors.initials: J
authors.lastname: Cubanski
authors.affiliation: Patricia Neuman is senior vice president and director of the Program on Medicare Policy at the Henry J. Kaiser Family Foundation in Washington, D.C.
authors.forename: Patricia
authors.initials: P
authors.lastname: Neuman
mesh_terms: D006801:Humans; D054524:Medicare Part D / Q000191:economics / Q000331:legislation & jurisprudence / Q000706:statistics & numerical data / Q000639:trends; D014481:United States
keywords: Medicare; Pharmaceuticals